These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 17692805)

  • 21. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
    Yang CH; Murti A; Pfeffer LM
    J Biol Chem; 2005 Sep; 280(36):31530-6. PubMed ID: 16009713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway.
    Roy P; Mukherjee T; Chatterjee B; Vijayaragavan B; Banoth B; Basak S
    Oncogene; 2017 Mar; 36(10):1417-1429. PubMed ID: 27641334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
    He L; Grammer AC; Wu X; Lipsky PE
    J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
    Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
    Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
    Liao G; Zhang M; Harhaj EW; Sun SC
    J Biol Chem; 2004 Jun; 279(25):26243-50. PubMed ID: 15084608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB; Samuel T; Reed JC
    Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
    Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
    Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
    Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
    J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
    Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
    Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct inhibition of elastase activity by indole-3-carbinol triggers a CD40-TRAF regulatory cascade that disrupts NF-kappaB transcriptional activity in human breast cancer cells.
    Aronchik I; Bjeldanes LF; Firestone GL
    Cancer Res; 2010 Jun; 70(12):4961-71. PubMed ID: 20530686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNFα induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2.
    Kim JY; Morgan M; Kim DG; Lee JY; Bai L; Lin Y; Liu ZG; Kim YS
    J Cell Sci; 2011 Feb; 124(Pt 4):647-56. PubMed ID: 21266470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
    Mazzera L; Abeltino M; Lombardi G; Cantoni AM; Ria R; Ricca M; Saltarella I; Naponelli V; Rizzi FMA; Perris R; Corradi A; Vacca A; Bonati A; Lunghi P
    Haematologica; 2019 Dec; 104(12):2465-2481. PubMed ID: 30948493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
    Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
    J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
    Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
    Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fourth IkappaB protein within the NF-kappaB signaling module.
    Basak S; Kim H; Kearns JD; Tergaonkar V; O'Dea E; Werner SL; Benedict CA; Ware CF; Ghosh G; Verma IM; Hoffmann A
    Cell; 2007 Jan; 128(2):369-81. PubMed ID: 17254973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.
    Kim YS; Nedospasov SA; Liu ZG
    Mol Cell Biol; 2005 Mar; 25(6):2130-7. PubMed ID: 15743811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.